RO6927005
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RO6927005, covering 2016-07-26 to 2016-07-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors [Phase 1]